Abstract
Background Little is known about the effect of persistent financial adversity across adulthood on cognitive ageing, and whether these impacts vary based on sex, childhood socioeconomic circumstances (SEC) and genetic risk.
Methods Using data from the 1946 Birth cohort study (N=2,759), with extensive data spanning over 70 years, as well as an embedded neuroimaging study (Insight46, N=356-468), we examined the prospective association between financial adversity (low household income, financial hardships; 26-53 years) and cognitive ageing (cognitive performance at 53 years; decline between 53-69 years, modelled using latent growth curve model; neuroimaging measures of brain health between 69-74 years), and the moderating role of sex, childhood SEC and APOE-4. Covariates included sex at birth, childhood SEC, childhood cognition (8 years), symptoms of depression and anxiety (13-15 years), and educational attainment (26 years).
Findings Increased exposure to low household income as well as financial hardships was associated with lower processing speed (SE: -0.07 [95% CI: -0.13, -0.02], -0.05 [-0.11, - 0.00], respectively) and verbal memory at age 53 (-0.16 [-0.21, -0.11], -0.10 [-0.15, -0.05] respectively). Increased exposure to financial adversity was also associated with slower verbal memory decline from 53 to 69 years, due to already lower baseline scores at 53 years. Persistent financial adversity was associated with greater ventricular volume at 69-71 years, and stronger associations between financial adversity and brain atrophy were found for males, those with lower childhood SEC, and APOE-4 carriers. APOE-4 carriers in particular were consistently more vulnerable to the effect of persistent financial adversity on brain atrophy.
Interpretation Persistent exposure to financial adversity influences cognitive performance by midlife and later-life brain atrophy, with impacts being larger for males, disadvantaged childhood SEC and individuals with greater genetic risk. These highlight the potential role of poverty reduction efforts in working-age adults for preventing dementia and promoting cognitive health in an ageing population.
Funding This study is funded by the UK Medical Research Council which provides core funding for the NSHD (MC_UU_00019/1 and MC_UU_00019/3). Insight 46 is funded by grants from Alzheimer’s Research UK (ARUK-PG2014-1946, ARUK-PG2017-1946: JMS, MR), Alzheimer’s Association (SG-666374-UK BIRTH COHORT: JMS), the Medical Research Council Dementias Platform UK (CSUB19166: JMS, MR), The Wolfson Foundation (PR/ylr/18575: JMS), The Medical Research Council (MC-UU-12019/1: Kuh and MC-UU-12019/3: MR), Selfridges Group Foundation (22/3/18: JMS), and Brain Research Trust (UCC14191: JMS). JS, JM and PP are also supported by funding from Alzheimer’s Society (Ref:469). TDP is supported by a NIHR clinical lectureship. JW is funded by the Belgian National Scientific Fund (FNRS) Research Associate Fellowship (CQ) no. 40010931.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study is funded by the UK Medical Research Council which provides core funding for the NSHD (MC_UU_00019/1 and MC_UU_00019/3). Insight 46 is funded by grants from Alzheimer s Research UK (ARUK-PG2014-1946, ARUK-PG2017-1946: JMS, MR), Alzheimer s Association (SG-666374-UK BIRTH COHORT: JMS), the Medical Research Council Dementias Platform UK (CSUB19166: JMS, MR), The Wolfson Foundation (PR/ylr/18575: JMS), The Medical Research Council (MC-UU-12019/1: Kuh and MC-UU-12019/3: MR), Selfridges Group Foundation (22/3/18: JMS), and Brain Research Trust (UCC14191: JMS). JS, JM and PP are also supported by funding from Alzheimer s Society (Ref:469). TDP is supported by a NIHR clinical lectureship. JW is funded by the Belgian National Scientific Fund (FNRS) Research Associate Fellowship (CQ) no. 40010931.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We used data from the MRC 1946 NSHD,a national British birth cohort. Ethical approval has been obtained from the Greater Manchester Local Research Ethics Committee and the Scotland Research Ethics Committee, and participants provided written informed consent at each data collection.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the University College London MRC unit for lifelong health and ageing (LHA).
